Delivery Order 36F79718D0355-36C26026F0055
Award Date 12/22/25
Potential Completion Date 12/21/26
Potential Value $1.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order to Alexion Pharmaceuticals Inc., a foreign-owned, for-profit biopharmaceutical company, to provide the pharmaceutical drug Strensiq 80mg. The contract, valued at $522,487.40, was awarded under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and does not have a set-aside designation. Alexion will perform the contract in Boston, Massachusetts, delivering Strensiq, which is used to treat the rare genetic disorder...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $187,948 delivery order to Alexion Pharmaceuticals Inc., doing business as Alexion, under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. Alexion will provide the drug Strensiq to the VA to treat patients from November 3, 2023 through January 31, 2024. The contract has a firm fixed price and will be performed in Boston, Massachusetts. This delivery order...
- This federal contract award is for the pharmaceutical drug Strensiq, provided by Alexion Pharmaceuticals Inc. to the U.S. Department of Veterans Affairs (VA). The contract, valued at $1,253,672.76, is a Firm Fixed Price Delivery Order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). Alexion, a foreign-owned, for-profit biopharmaceutical company, is the prime contractor. The contract is to be performed in Carrollton, Texas and has an ultimate completion date of December 21, 2025....
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Alexion Pharmaceuticals Inc., a foreign-owned for-profit biopharmaceutical company. The contract is for the supply of the drug Soliris, under Alexion's GSA Schedule contract for Pharmaceuticals and Drugs. The potential value of this specific delivery order is $111,167.52, with a completion date of December 30, 2017. There was no set-aside designation used for this award....
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Alexion Pharmaceuticals Inc. for the drug Soliris 300 mg vial. The contract was awarded under the GSA Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB), with a firm-fixed-price pricing type. The contract has a ceiling value of $89,993.19 and a period of performance ending on December 31, 2015. Alexion, a global biopharmaceutical company, is the prime contractor and there are no noted...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Amicus Therapeutics US, LLC on October 29, 2025, for the supply of Galafold 123 mg, a specialized pharmaceutical product used to treat Fabry disease. This firm fixed-price delivery order, valued at $21,891.21 with completion scheduled for October 31, 2025, will be delivered to a VA facility in Philadelphia, Pennsylvania. The award was made under the Pharmaceuticals and Drugs...
- This is a firm fixed-price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) schedule contract, awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The award, valued at $217,000.00, is for the supply of 1,200 vials of the drug GLASSIA (alpha 1-proteinase inhibitor human, 1 gram/50 milliliters) for the VA's fiscal year 2016 requirements. The contract has a period of performance ending on September 30, 2016 and...
- The Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a $28,975.20 delivery order to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a specialized pharmaceutical used to treat cystinuria and related kidney disorders. This award, issued on November 5, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order issued under Travere's existing Federal Supply Schedule contract for Pharmaceuticals and...
- The Department of Veterans Affairs Veterans Health Administration awarded Insmed Incorporated a $53,550.49 delivery order against its Pharmaceuticals and Drugs GSA Schedule to provide emergency supplies of the antibiotic amikacin through December 2023. As the prime contractor, Insmed will deliver the drug from its Carrollton, Texas facility to support VHA's efforts through Veterans Integrated Service Network 22. Insmed will perform on a firm-fixed-price basis over the six-month ordering period...
- Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, received a $48.6K delivery order from Veterans Integrated Service Network 20 (VISN 20) on October 3, 2024, for the supply of ADZYNMA 1500IU injectable lyophilized medication. The award is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) with no set-aside designation, reflecting the specialized and limited-source nature of the...